4.5 Article

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study

Journal

TRANSPLANT INTERNATIONAL
Volume 24, Issue 7, Pages 651-656

Publisher

WILEY
DOI: 10.1111/j.1432-2277.2011.01248.x

Keywords

bronchiolitis obliterans syndrome; chronic rejection; lung transplantation; montelukast

Funding

  1. Research Foundation Flanders (FWO) [G.0643.08, G.0723.10]
  2. Onderzoeksfonds K.U.Leuven [OT/10/050]

Ask authors/readers for more resources

Bronchiolitis obliterans syndrome (BOS) remains the major hurdle to improve long-term survival after lung transplantation, as its treatment remains troublesome. In this pilot study, we investigated the effect of montelukast (a leukotriene receptor antagonist) on the FEV1 decline after diagnosis of BOS and compared this with a control group. In both groups, 11 patients were included with BOS stage <3 and bronchoalveolar lavage (BAL) neutrophilia <15%, already being treated or concurrently being started on azithromycin. Control patients were selected retrospectively. After adding montelukast (10 mg/day) to the immunosuppressive regimen, the FEV1 decline significantly decreased from 112 +/- 26 ml/month before BOS diagnosis to 13 +/- 13 ml/month after 6 months of montelukast therapy (P = 0.001). In the control group, there was no significant change in the rate of FEV1 decline: 103 +/- 20 ml/month before BOS diagnosis to 114 +/- 27 ml/month (P = 0.55). Adding montelukast may be a promising treatment option in patients with low neutrophilic (<15%) BOS after lung transplantation, already or concurrently being treated with azithromycin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

Commentary: Recipient-tailored segmental lung transplantation: First aid kit for kids in urgent need?

Dirk Van Raemdonck, Laurens J. Ceulemans, Robin Vos, Geert M. Verleden

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2023)

Editorial Material Surgery

Endovascular transatrial stenting of pulmonary vein stenosis after lung transplantation

Michaela Orlitova, Marc Gewillig, Jan Van Slambrouck, Dirk Vlasselaers, Bart Jacobs, Arne P. Neyrinck, Lieven Depypere, Laurent Godinas, Robin Vos, Geert M. Verleden, Dirk E. Van Raemdonck, Laurens J. Ceulemans

Summary: Pulmonary vein stenosis (PVS) and pulmonary vein occlusion (PVO) are rare complications after lung transplantation (LTx) with limited treatment options and a high risk of graft loss. We describe two cases of successful endovascular transatrial stenting following double LTx. Both patients, one with chronic obstructive pulmonary disease and the other with idiopathic pulmonary arterial hypertension, underwent endovascular transatrial dilatation and stenting to treat PVS and PVO respectively, avoiding the need for surgical reintervention. This treatment option appears to be effective and safe for these life-threatening complications after LTx.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Oncology

Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Disseminated Thymoma: A Systematic Literature Review

Tom Vandaele, Jan Van Slambrouck, Viktor Proesmans, Paul Clement, Maarten Lambrecht, Philippe Nafteux, Dirk Van Raemdonck, Laurens J. Ceulemans

Summary: This review provides an overview of the current literature on hyperthermic intrathoracic chemotherapy (HITHOC) for thymoma with pleural dissemination (TPD). The results suggest that combining cytoreductive surgery and HITHOC is feasible and safe for TPD, but there is significant heterogeneity in the literature, calling for further research to better understand the additional benefit of HITHOC in TPD treatment.

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Disseminated Thymoma-A Systematic Literature Review

Tom Vandaele, Jan Van Slambrouck, Viktor Proesmans, Paul Clement, Maarten Lambrecht, Philippe Nafteux, Dirk Van Raemdonck, Laurens J. Ceulemans

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Cardiac & Cardiovascular Systems

The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution

Laura P. M. H. de Rooij, Lisa M. Becker, Laure Anne Teuwen, Bram Boeckx, Sander Jansen, Simon Feys, Stijn Verleden, Laurens Liesenborghs, Anna K. Stalder, Sasha Libbrecht, Tina Van Buyten, Gino Philips, Abhishek Subramanian, Sebastien J. Dumas, Elda Meta, Mila Borri, Liliana Sokol, Amelie Dendooven, Anh Co K. Truong, Jan Gunst, Pierre Van Mol, Jasmin D. Haslbauer, Katerina Rohlenova, Thomas Menter, Robbert Boudewijns, Vincent Geldhof, Stefan Vinckier, Jacob Amersfoort, Wim Wuyts, Dirk Van Raemdonck, Werner Jacobs, Laurens J. Ceulemans, Birgit Weynand, Bernard Thienpont, Martin Lammens, Mark Kuehnel, Guy Eelen, Mieke Dewerchin, Luc Schoonjans, Danny Jonigk, Jo van Dorpe, Alexandar Tzankov, Els Wauters, Massimiliano Mazzone, Johan Neyts, Joost Wauters, Diether Lambrechts, Peter Carmeliet

Summary: This study provides new insights into the abundance, expression patterns, and interactomes of endothelial cell (EC) subtypes in COVID-19 and idiopathic pulmonary fibrosis (IPF). The findings suggest the importance of ECs in the pathophysiology of both conditions and may contribute to future investigations into the progression and treatment of COVID-19 and IPF.

CARDIOVASCULAR RESEARCH (2023)

Article Surgery

Lung Transplant Outcome From Selected Older Donors (& GE;70 Years) Equals Younger Donors (<70 Years) A Propensity-matched Analysis

Cedric Vanluyten, Christelle M. Vandervelde, Robin Vos, Jan Van Slambrouck, Steffen Fieuws, Paul De Leyn, Philippe Nafteux, Herbert Decaluwe, Hans Van Veer, Lieven Depypere, Yanina Jansen, An-Lies Provoost, Arne P. Neyrinck, Catherine Ingels, Bart M. Vanaudenaerde, Laurent Godinas, Lieven J. Dupont, Geert M. Verleden, Dirk Van Raemdonck, Laurens J. Ceulemans

Summary: This study retrospectively analyzed single-center bilateral lung transplantations performed between 2010 and 2020. The results showed that lung transplantation from donors aged ≥70 years is feasible and safe, with comparable short and long-term outcomes to transplantation from younger donors.

ANNALS OF SURGERY (2023)

Review Pharmacology & Pharmacy

Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction

Saskia Bos, Pauline Pradere, Hanne Beeckmans, Andrea Zajacova, Bart M. Vanaudenaerde, Andrew J. Fisher, Robin Vos

Summary: Chronic lung rejection, also known as chronic lung allograft dysfunction (CLAD), is a major obstacle for long-term survival after lung transplantation. Limited therapeutic options are available, but lymphocyte depleting and immunomodulating therapies such as extracorporeal photopheresis, anti-thymocyte globulin, and total lymphoid irradiation appear to be the most effective treatments for progressive CLAD patients, considering both efficacy and risk of side effects.

PHARMACOLOGICAL REVIEWS (2023)

Article Respiratory System

Activation of epithelial and inflammatory pathways in adolescent elite athletes exposed to intense exercise and air pollution

Janne Goossens, Anne-Charlotte Jonckheere, Sven F. Seys, Ellen Dilissen, Tatjana Decaesteker, Camille Goossens, Koen Peers, Vincent Vanbelle, Jeroen Stappers, Sven Aertgeerts, Barbara De Wilde, Jasmine Leus, Sophie Verelst, Marc Raes, Lieven Dupont, Dominique M. Bullens

Summary: The study investigated the effects of intense exercise and air pollution exposure on the airway barrier and exercise-induced bronchoconstriction (EIB) in adolescent elite athletes. Results showed that athletes had increased markers of air pollution exposure, epithelial damage, and airway inflammation compared with controls. The incidence of EIB in athletes was also linked to prior exposure to PM10 and PM2.5.

THORAX (2023)

Article Physiology

Extensive profiling of histidine-containing dipeptides reveals species- and tissue-specific distribution and metabolism in mice, rats, and humans

Thibaux Van der Stede, Jan Spaas, Sarah de Jager, Jana De Brandt, Camilla Hansen, Jan Stautemas, Bjarne Vercammen, Siegrid De Baere, Siska Croubels, Charles-Henri Van Assche, Berta Cillero Pastor, Michiel Vandenbosch, Ruud Van Thienen, Kenneth Verboven, Dominique Hansen, Thierry Bove, Bruno Lapauw, Charles Van Praet, Karel Decaestecker, Bart Vanaudenaerde, Bert O. Eijnde, Lasse Gliemann, Ylva Hellsten, Wim Derave

Summary: This study systematically analyzed the distribution and metabolism of histidine-containing dipeptides (HCDs) in mouse, rat, and human tissues using a sensitive UHPLC-MS/MS approach. The results show that tissue HCD levels are uniquely produced by carnosine synthase (CARNS1) in fast-twitch skeletal muscle fibers and brain oligodendrocytes. Additionally, N-acetylcarnosine is a stable plasma HCD and is enriched in human skeletal muscles.

ACTA PHYSIOLOGICA (2023)

Article Physiology

The hemodynamic interplay between pulmonary ischemia-reperfusion injury and right ventricular function in lung transplantation: a translational porcine model

Michaela Orlitova, Tom Verbelen, Anna E. Frick, Arno Vanstapel, Dieter Van Beersel, Sofie Ordies, Jan Van Slambrouck, Janne Kaes, Xin Jin, Walter Coudyzer, Stijn E. Verleden, Geert M. Verleden, Bart M. Vanaudenaerde, Dirk E. Van Raemdonck, Robin Vos, Laurens J. Ceulemans, Piet Claus, Arne P. Neyrinck

Summary: Lung transplantation is a challenging procedure and can result in severe damage to the transplanted pulmonary graft. The interaction between right ventricular function and lung injury during the transplantation process is poorly understood. Through a translational porcine model, it was found that right ventricular failure can occur as a result of forcing the entire cardiac output through a lung suffering from ischemia-reperfusion injury. The study also revealed a delicate balance between the development of pulmonary ischemia-reperfusion injury and right ventricular function, highlighting the potential benefits of extracorporeal life support technology in these cases.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2023)

Article Biochemistry & Molecular Biology

Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients

Seppe Cambier, Fabio Beretta, Noemie Portner, Mieke Metzemaekers, Ana Carolina de Carvalho, Erik Martens, Janne Kaes, Celine Aelbrecht, Cato Jacobs, Pierre Van Mol, Els Wauters, Philippe Meersseman, Greet Hermans, Rafael Elias Marques, Bart Vanaudenaerde, Robin Vos, Joost Wauters, Mieke Gouwy, Paul Proost

Summary: CXCL12, which is present in the lungs and circulation of COVID-19 patients, undergoes rapid proteolytic processing and degradation. The proteolysis is mainly mediated by neutrophil elastase in COVID-19 BAL fluids with high proteolytic activity.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Respiratory System

COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT

Vincent Geudens, Jan Van Slambrouck, Gitte Aerts, Lynn Willems, Tinne Goos, Janne Kaes, Andrea Zajacova, Iwein Gyselinck, Celine Aelbrecht, Astrid Vermaut, Hanne Beeckmans, Marie Vermant, Charlotte De Fays, Annelore Sacreas, Lucia Aversa, Michaela Orlitova, Arno Vanstapel, Ivan Josipovic, Matthieu N. Boone, John E. McDonough, Birgit Weynand, Charles Pilette, Wim Janssens, Lieven Dupont, Wim A. Wuyts, Geert M. Verleden, Dirk E. van Raemdonck, Robin Vos, Ghislaine Gayan-Ramirez, Laurens J. Ceulemans, Bart M. Vanaudenaerde

Summary: This study assessed disease progression in COVID-19 patients using in vivo CT and ex vivo microCT, and described the changes in lung volume and density as well as airway morphology. Results showed that COVID-19 lung volumes decreased and densities increased over time, mainly in the lower lobes. Ex vivo microCT revealed a 60% reduction in lung volume compared to controls, and increased visibility of airways in COVID-19 lungs, possibly due to fibrosis and increased airway diameter. Small-partition microCT further showed deformations in airway morphology and heterogeneous fibrotic organization in severely affected regions, which was confirmed by histology.

JOURNAL OF THORACIC DISEASE (2023)

Meeting Abstract Critical Care Medicine

Morphometrics and Mucosal Immune Features in Lungs With End-stage Chronic Obstructive Pulmonary Disease

C. De Fays, H. Beeckmans, P. Kerckhof, V. Geudens, A. Vermaut, I. Gyselinck, T. Goos, M. Vermant, J. Kaes, J. Van Slambrouck, Y. Mohamady, L. Willems, L. Aversa, K. Maes, C. Aelbrecht, S. Everaerts, J. E. Mcdonough, L. J. De Sadeleer, S. Gohy, J. Ambroise, W. A. Wuyts, W. L. Janssens, L. J. Ceulemans, D. E. M. Van Raemdonck, R. Vos, T. Hackett, J. C. Hogg, N. Kaminski, C. Pilette, G. Gayan-Ramirez, B. Vanaudenaerde

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Urgent lung volume reduction surgery is effective for secondary pneumothorax in emphysema patients

Annalisa Barbarossa, Dirk Van Raemdonck, Walter Weder, Laurens J. Ceulemans

Summary: Secondary pneumothorax due to emphysema is a life-threatening condition that often requires surgery. In this case, we used LVRS to not only remove part of the lung but also close the fistula. The patient experienced improved lung function and quality of life after urgent and elective LVRS surgeries, with resolution of the air leak.

INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY (2023)

Article Biochemical Research Methods

The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid

Jan Van Slambrouck, Charlotte Schoenaers, Lies Laenen, Xin Jin, Kurt Beuselinck, Ann Verdonck, Joost Wauters, Geert Molenberghs, Bart M. Vanaudenaerde, Robin Vos, Peter Mombaerts, Katrien Lagrou, Laurens J. Ceulemans

Summary: The ability to detect SARS-CoV-2 RNA or antigen in BAL fluid samples using point-of-care tests (POCTs) can reduce the risk of developing severe COVID-19 after lung transplantation.

JOURNAL OF VIROLOGICAL METHODS (2024)

No Data Available